| Company Announcements: (reported by the Company) |
No items found
|
| Elevator Pitch: | Infertility affects 1 in 6 couples globally, especially those over the age of 35. In vitro fertilisation (IVF) offers a potential solution, with embryo selection being a critical step in the process. Current market solutions have a success rate of only 20% to 30%, often requiring couples to undergo multiple cycles to achieve a clinical pregnancy. This not only incurs significant costs but also subjects couples to the emotional and physical toll of repeated miscarriages. At InnovaIVF, we are developing a cutting-edge medical device that evaluates embryo viability through a novel biological marker: metabolic activity. This innovation aims to enhance the accuracy of embryo selection, providing more cost-effective treatments and a better overall experience for both patients and healthcare providers. |
| Category: | Health & biotech |
| URL: | https://www.monash.edu/monash-innovation/impact/generator-founders/innova-ivf |
| Operational Status: | Active |
| ASX Listing Code (if applicable): | |
| Year of Commencement: | |
| Address: | GLEN HUNTLY VIC 3163 |
| State: | Victoria |
| Overseas Operations: | No |
| X: | |
| Facebook: | |
| Linkedin: | https://www.linkedin.com/company/innovaivf/ |
| Founders: | |
| Awards won: | |
